Smith & Nephew (SNN) Stock Forecast, Price Target & Predictions
SNN Stock Forecast
Smith & Nephew stock forecast is as follows: an average price target of $27.00 (represents a 9.49% upside from SNN’s last price of $24.66) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
SNN Price Target
The average price target for Smith & Nephew (SNN) is $27.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $27.00. This represents a potential 9.49% upside from SNN's last price of $24.66.
SNN Analyst Ratings
According to 6 Wall Street analysts, Smith & Nephew's rating consensus is 'Buy'. The analyst rating breakdown for SNN stock is 0 'Strong Buy' (0.00%), 3 'Buy' (50.00%), 3 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Smith & Nephew Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Kyle Rose | Canaccord Genuity | $27.00 | $25.28 | 6.80% | 9.49% |
The latest Smith & Nephew stock forecast, released on Nov 04, 2024 by Kyle Rose from Canaccord Genuity, set a price target of $27.00, which represents a 6.80% increase from the stock price at the time of the forecast ($25.28), and a 9.49% increase from SNN last price ($24.66).
Smith & Nephew Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $27.00 | $27.00 |
| Last Closing Price | $24.66 | $24.66 | $24.66 |
| Upside/Downside | -100.00% | 9.49% | 9.49% |
In the current month, the average price target of Smith & Nephew stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Smith & Nephew's last price of $24.66. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 04, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Oct 14, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Aug 02, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jul 24, 2024 | Deutsche Bank | Buy | Initialise | |
| Jun 05, 2024 | UBS | Neutral | Buy | Upgrade |
| May 22, 2024 | Liberum | Hold | Downgrade | |
| Oct 04, 2022 | Barclays | Overweight | Overweight | Hold |
| Aug 04, 2022 | Barclays | Overweight | Overweight | Hold |
| Apr 29, 2022 | UBS | Neutral | Neutral | Hold |
Smith & Nephew's last stock rating was published by Canaccord Genuity on Nov 04, 2024. The company gave SNN a "Hold" rating, the same as its previous rate.
Smith & Nephew Financial Forecast
Smith & Nephew Revenue Forecast
| Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $668.50M | - | - | - | - | - | - | - | - | $1.07B | $1.07B | $1.08B | $1.05B | $995.00M | $865.00M | $911.00M | $744.00M | $643.00M | $628.00M | $558.40M | $516.54M |
| Avg Forecast | $1.44B | $3.00B | $2.84B | $1.45B | $2.93B | $1.43B | $2.67B | $2.73B | $2.42B | $2.20B | $2.00B | $1.82B | $1.66B | $1.51B | $1.37B | $1.24B | $1.13B | $1.10B | $1.08B | $1.03B | $877.94M | $830.40M | $944.74M | $744.00M | $675.15M | $628.00M | $587.79M | $497.41M |
| High Forecast | $1.44B | $3.00B | $2.85B | $1.45B | $3.52B | $1.43B | $3.20B | $3.27B | $2.91B | $2.64B | $2.40B | $2.19B | $1.99B | $1.81B | $1.64B | $1.49B | $1.36B | $1.32B | $1.29B | $1.23B | $1.05B | $996.48M | $1.13B | $892.80M | $810.18M | $753.60M | $705.34M | $596.89M |
| Low Forecast | $1.44B | $2.99B | $2.84B | $1.45B | $2.35B | $1.43B | $2.13B | $2.18B | $1.94B | $1.76B | $1.60B | $1.46B | $1.32B | $1.20B | $1.09B | $995.28M | $904.80M | $882.63M | $863.20M | $820.56M | $702.35M | $664.32M | $755.79M | $595.20M | $540.12M | $502.40M | $470.23M | $397.93M |
| # Analysts | 1 | 2 | 1 | 9 | 19 | 10 | 15 | 15 | 18 | 20 | 13 | 20 | 12 | 15 | 13 | 12 | 15 | 16 | 16 | 9 | 9 | 11 | 17 | 16 | 16 | 17 | 11 | 12 |
| Surprise % | - | - | - | - | - | - | - | 0.25% | - | - | - | - | - | - | - | - | 0.95% | 0.97% | 1.00% | 1.03% | 1.13% | 1.04% | 0.96% | 1.00% | 0.95% | 1.00% | 0.95% | 1.04% |
Smith & Nephew's average Quarter revenue forecast for Mar 23 based on 15 analysts is $2.67B, with a low forecast of $2.13B, and a high forecast of $3.20B. SNN's average Quarter revenue forecast represents a 298.93% increase compared to the company's last Quarter revenue of $668.50M (Dec 22).
Smith & Nephew EBITDA Forecast
| Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 1 | 9 | 19 | 10 | 15 | 15 | 18 | 20 | 13 | 20 | 12 | 15 | 13 | 12 | 15 | 16 | 16 | 9 | 9 | 11 | 17 | 16 | 16 | 17 | 11 | 12 |
| EBITDA | - | - | - | - | - | - | - | $-1.03B | - | - | - | - | - | - | - | - | $320.00M | $296.00M | $316.00M | $304.00M | $309.00M | $223.00M | $235.00M | $195.00M | $166.00M | $164.00M | $131.68M | $136.25M |
| Avg Forecast | $307.07M | $637.89M | $605.56M | $308.41M | $874.86M | $304.84M | $795.33M | $770.96M | $723.03M | $657.30M | $597.54M | $543.22M | $493.84M | $448.94M | $408.13M | $371.03M | $337.30M | $303.79M | $316.00M | $295.56M | $270.88M | $211.20M | $212.59M | $178.00M | $519.75M | $171.00M | $138.75M | $129.95M |
| High Forecast | $307.28M | $638.71M | $605.96M | $308.62M | $1.05B | $305.04M | $954.40M | $925.16M | $867.63M | $788.76M | $717.05M | $651.86M | $592.60M | $538.73M | $489.76M | $445.23M | $404.76M | $364.55M | $379.20M | $354.67M | $325.06M | $253.44M | $255.11M | $213.60M | $623.70M | $205.20M | $166.50M | $155.95M |
| Low Forecast | $306.87M | $637.07M | $605.16M | $308.21M | $699.89M | $304.64M | $636.26M | $616.77M | $578.42M | $525.84M | $478.03M | $434.58M | $395.07M | $359.15M | $326.50M | $296.82M | $269.84M | $243.03M | $252.80M | $236.44M | $216.71M | $168.96M | $170.07M | $142.40M | $415.80M | $136.80M | $111.00M | $103.96M |
| Surprise % | - | - | - | - | - | - | - | -1.33% | - | - | - | - | - | - | - | - | 0.95% | 0.97% | 1.00% | 1.03% | 1.14% | 1.06% | 1.11% | 1.10% | 0.32% | 0.96% | 0.95% | 1.05% |
12 analysts predict SNN's average Quarter EBITDA for Mar 15 to be $371.03M, with a high of $445.23M and a low of $296.82M. This is 15.95% upper than Smith & Nephew's previous annual EBITDA (Mar 14) of $320.00M.
Smith & Nephew Net Income Forecast
| Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 1 | 9 | 19 | 10 | 15 | 15 | 18 | 20 | 13 | 20 | 12 | 15 | 13 | 12 | 15 | 16 | 16 | 9 | 9 | 11 | 17 | 16 | 16 | 17 | 11 | 12 |
| Net Income | - | - | - | - | - | - | - | $-367.00M | - | - | - | - | - | - | - | - | $150.00M | $143.00M | $161.00M | $156.00M | $159.00M | $98.00M | $83.00M | $91.00M | $85.00M | $93.00M | $76.16M | $69.30M |
| Avg Forecast | - | $844.64M | $1.35B | $698.78M | $410.09M | $847.27M | $372.81M | $349.45M | $338.92M | $308.11M | $280.10M | $254.63M | $231.49M | $210.44M | $191.31M | $173.92M | $158.11M | $146.76M | $161.00M | $151.67M | $140.29M | $94.08M | $86.07M | $91.00M | $437.85M | $93.00M | $80.17M | $66.73M |
| High Forecast | - | $845.37M | $1.35B | $699.38M | $492.11M | $848.00M | $447.37M | $419.33M | $406.70M | $369.73M | $336.12M | $305.56M | $277.78M | $252.53M | $229.57M | $208.70M | $189.73M | $176.12M | $193.20M | $182.00M | $168.35M | $112.90M | $103.29M | $109.20M | $525.42M | $111.60M | $96.20M | $80.08M |
| Low Forecast | - | $843.92M | $1.35B | $698.17M | $328.07M | $846.53M | $298.25M | $279.56M | $271.14M | $246.49M | $224.08M | $203.71M | $185.19M | $168.35M | $153.05M | $139.14M | $126.49M | $117.41M | $128.80M | $121.33M | $112.24M | $75.26M | $68.86M | $72.80M | $350.28M | $74.40M | $64.14M | $53.39M |
| Surprise % | - | - | - | - | - | - | - | -1.05% | - | - | - | - | - | - | - | - | 0.95% | 0.97% | 1.00% | 1.03% | 1.13% | 1.04% | 0.96% | 1.00% | 0.19% | 1.00% | 0.95% | 1.04% |
Smith & Nephew's average Quarter net income forecast for Mar 15 is $173.92M, with a range of $139.14M to $208.70M. SNN's average Quarter net income forecast represents a 15.95% increase compared to the company's last Quarter net income of $150.00M (Mar 14).
Smith & Nephew SG&A Forecast
| Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 1 | 9 | 19 | 10 | 15 | 15 | 18 | 20 | 13 | 20 | 12 | 15 | 13 | 12 | 15 | 16 | 16 | 9 | 9 | 11 | 17 | 16 | 16 | 17 | 11 | 12 |
| SG&A | - | - | - | - | - | - | - | $-4.14B | - | - | - | - | - | - | - | - | $520.00M | $547.00M | $529.00M | $508.00M | $464.00M | $441.00M | $440.00M | $371.00M | $315.00M | $317.00M | $269.75M | - |
| Avg Forecast | $726.68M | $1.51B | $1.43B | $729.85M | $1.42B | $721.39M | $1.29B | $696.71M | $1.17B | $1.07B | $971.01M | $882.73M | $802.49M | $729.53M | $663.21M | $602.92M | $548.11M | $561.39M | $529.00M | $493.89M | $409.41M | $423.36M | $456.30M | $371.00M | $330.75M | $317.00M | $283.94M | $248.21M |
| High Forecast | $727.16M | $1.51B | $1.43B | $730.33M | $1.71B | $721.87M | $1.55B | $836.05M | $1.41B | $1.28B | $1.17B | $1.06B | $962.98M | $875.44M | $795.85M | $723.50M | $657.73M | $673.67M | $634.80M | $592.67M | $491.29M | $508.03M | $547.56M | $445.20M | $396.90M | $380.40M | $340.73M | $297.85M |
| Low Forecast | $726.20M | $1.51B | $1.43B | $729.36M | $1.14B | $720.91M | $1.03B | $557.37M | $939.93M | $854.49M | $776.81M | $706.19M | $641.99M | $583.63M | $530.57M | $482.34M | $438.49M | $449.12M | $423.20M | $395.11M | $327.53M | $338.69M | $365.04M | $296.80M | $264.60M | $253.60M | $227.16M | $198.57M |
| Surprise % | - | - | - | - | - | - | - | -5.94% | - | - | - | - | - | - | - | - | 0.95% | 0.97% | 1.00% | 1.03% | 1.13% | 1.04% | 0.96% | 1.00% | 0.95% | 1.00% | 0.95% | - |
Smith & Nephew's average Quarter SG&A projection for Mar 15 is $602.92M, based on 12 Wall Street analysts, with a range of $482.34M to $723.50M. The forecast indicates a 15.95% rise compared to SNN last annual SG&A of $520.00M (Mar 14).
Smith & Nephew EPS Forecast
| Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 1 | 9 | 19 | 10 | 15 | 15 | 18 | 20 | 13 | 20 | 12 | 15 | 13 | 12 | 15 | 16 | 16 | 9 | 9 | 11 | 17 | 16 | 16 | 17 | 11 | 12 |
| EPS | - | - | - | - | - | - | - | $-0.82 | - | - | - | - | - | - | - | - | $0.34 | $0.32 | $0.36 | $0.35 | $0.36 | $0.22 | $0.19 | $0.19 | $0.18 | $19.80 | $0.16 | $0.15 |
| Avg Forecast | - | $0.97 | $1.54 | $0.80 | $1.58 | $0.97 | $1.43 | $1.95 | $1.43 | $0.76 | $0.69 | $0.63 | $0.57 | $0.52 | $0.47 | $0.43 | $0.39 | $0.39 | $0.39 | $0.35 | $0.30 | $0.24 | $0.28 | $0.22 | $0.21 | $0.20 | $0.20 | $0.26 |
| High Forecast | - | $0.97 | $1.54 | $0.80 | $1.58 | $0.97 | $1.43 | $1.96 | $1.43 | $0.92 | $0.84 | $0.76 | $0.69 | $0.63 | $0.57 | $0.52 | $0.47 | $0.47 | $0.47 | $0.42 | $0.36 | $0.29 | $0.34 | $0.26 | $0.25 | $0.24 | $0.24 | $0.31 |
| Low Forecast | - | $0.97 | $1.54 | $0.80 | $1.58 | $0.97 | $1.43 | $1.95 | $1.43 | $0.61 | $0.55 | $0.50 | $0.45 | $0.41 | $0.37 | $0.34 | $0.31 | $0.31 | $0.31 | $0.28 | $0.24 | $0.19 | $0.22 | $0.18 | $0.17 | $0.16 | $0.16 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | -0.42% | - | - | - | - | - | - | - | - | 0.87% | 0.82% | 0.92% | 1.00% | 1.20% | 0.92% | 0.68% | 0.86% | 0.86% | 99.00% | 0.80% | 0.58% |
According to 12 Wall Street analysts, Smith & Nephew's projected average Quarter EPS for Mar 15 is $0.43, with a low estimate of $0.34 and a high estimate of $0.52. This represents a 26.47% increase compared to SNN previous annual EPS of $0.34 (Mar 14).
Smith & Nephew Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| ATEC | Alphatec | $9.52 | $16.60 | 74.37% | Buy |
| LIVN | LivaNova | $49.94 | $68.25 | 36.66% | Buy |
| BRKR | Bruker | $57.81 | $79.00 | 36.65% | Buy |
| CNMD | CONMED | $71.23 | $97.00 | 36.18% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| IRTC | iRhythm | $91.45 | $111.38 | 21.79% | Buy |
| ITGR | Integer | $136.68 | $153.50 | 12.31% | Buy |
| FNA | Paragon 28 | $10.36 | $11.50 | 11.00% | Buy |
| SNN | Smith & Nephew | $25.44 | $27.00 | 6.13% | Buy |
| GMED | Globus Medical | $83.42 | $85.00 | 1.89% | Buy |
| GKOS | Glaukos | $146.35 | $144.14 | -1.51% | Buy |